Dudediligence.

Vera Therapeutics, Inc

VERANASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$46.6MSep ’24−$43.4MDec ’24−$51.7MMar ’25−$76.5MJun ’25−$80.3MSep ’25−$91.1MDec ’25−$121.0MMar ’26−$109.5MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$34.4M−$90.9M−$102.0M−$167.2M−$315.5M
Net income−$32.6M−$89.1M−$96.0M−$152.1M−$299.6M
Operating cash flow−$23.7M−$67.6M−$92.2M−$134.7M−$241.1M
Free cash flow−$23.7M−$67.7M−$92.2M−$135.7M−$241.7M
Cash$79.7M$43.5M$45.7M$92.6M$354.7M
Debt$4.9M$24.8M$49.9M$50.7M$74.8M
Shares outstanding13.4M26.6M42.7M55.3M64.2M